311 related articles for article (PubMed ID: 30136085)
1. Vitamin D and calcium kidney stones: a review and a proposal.
Tavasoli S; Taheri M
Int Urol Nephrol; 2019 Jan; 51(1):101-111. PubMed ID: 30136085
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D and kidney stone disease.
Tang J; Chonchol MB
Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):383-9. PubMed ID: 23739765
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D status in patients with recurrent kidney stones.
Pipili C; Oreopoulos DG
Nephron Clin Pract; 2012; 122(3-4):134-8. PubMed ID: 23712072
[TBL] [Abstract][Full Text] [Related]
4. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
5. Analysis of vitamin D deficiency in calcium stone-forming patients.
Girón-Prieto MS; Del Carmen Cano-García M; Arrabal-Polo MÁ; Poyatos-Andujar A; Quesada-Charneco M; de Haro-Muñoz T; Arias-Santiago S; Arrabal-Martín M
Int Urol Nephrol; 2016 Aug; 48(8):1243-1246. PubMed ID: 27093967
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D Repletion in Kidney Stone Formers: A Randomized Controlled Trial.
Ferroni MC; Rycyna KJ; Averch TD; Semins MJ
J Urol; 2017 Apr; 197(4):1079-1083. PubMed ID: 27765695
[TBL] [Abstract][Full Text] [Related]
7. The Prevalence of Vitamin D Deficiency, Its Predisposing Factors and Association with 24-hour Urine Metabolites Among Iranian Kidney Stone Formers.
Tavasoli S; Taheri F; Bagheri Amiri F; Borumandnia N; Basiri A; Parvin M; Taheri M
Iran J Kidney Dis; 2021 Jul; 15(4):263-269. PubMed ID: 34278997
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D, Hypercalciuria and Kidney Stones.
Letavernier E; Daudon M
Nutrients; 2018 Mar; 10(3):. PubMed ID: 29562593
[TBL] [Abstract][Full Text] [Related]
9. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction pose any risk?
Johri N; Jaeger P; Ferraro PM; Shavit L; Nair D; Robertson WG; Gambaro G; Unwin RJ
Urolithiasis; 2017 Dec; 45(6):535-543. PubMed ID: 27981376
[TBL] [Abstract][Full Text] [Related]
11. Effect of two vitamin D repletion protocols on 24-h urine calcium in patients with recurrent calcium kidney stones and vitamin D deficiency: a randomized clinical trial.
Sardari Masihi L; Borumandnia N; Taheri M; Basiri A; Imani H; Jalali S; Tavasoli S
Eur J Med Res; 2023 Jul; 28(1):246. PubMed ID: 37481570
[TBL] [Abstract][Full Text] [Related]
12. Metabolic effects of cholecalciferol supplementation in patients with calcium nephrolithiasis and vitamin D deficiency.
Vitale C; Marangella M; Bermond F; Fabbrini L; Tricerri A
World J Urol; 2021 Feb; 39(2):597-603. PubMed ID: 32367158
[TBL] [Abstract][Full Text] [Related]
13. Nephrocalcinosis in Calcium Stone Formers Who Do Not have Systemic Disease.
Bhojani N; Paonessa JE; Hameed TA; Worcester EM; Evan AP; Coe FL; Borofsky MS; Lingeman JE
J Urol; 2015 Nov; 194(5):1308-12. PubMed ID: 25988516
[TBL] [Abstract][Full Text] [Related]
14. Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers.
Leaf DE; Korets R; Taylor EN; Tang J; Asplin JR; Goldfarb DS; Gupta M; Curhan GC
Clin J Am Soc Nephrol; 2012 May; 7(5):829-34. PubMed ID: 22422535
[TBL] [Abstract][Full Text] [Related]
15. Calcium and Vitamin D Supplementation and Their Association with Kidney Stone Disease: A Narrative Review.
Bargagli M; Ferraro PM; Vittori M; Lombardi G; Gambaro G; Somani B
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959915
[TBL] [Abstract][Full Text] [Related]
16. Metabolic abnormalities and the medical management of calcium oxalate nephrolithiasis.
Chandhoke PS
Minerva Urol Nefrol; 2005 Mar; 57(1):9-16. PubMed ID: 15944517
[TBL] [Abstract][Full Text] [Related]
17. Changes in renal papillary density after hydration therapy in calcium stone formers.
Ferraro PM; Vittori M; Macis G; D'Addessi A; Lombardi G; Palmisano C; Gervasoni J; Primiano A; Bassi PF; Gambaro G
BMC Urol; 2018 Nov; 18(1):101. PubMed ID: 30419887
[TBL] [Abstract][Full Text] [Related]
18. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P
Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
[TBL] [Abstract][Full Text] [Related]
19. Kidney stone formers have more renal parenchymal crystals than non-stone formers, particularly in the papilla region.
Okada A; Hamamoto S; Taguchi K; Unno R; Sugino T; Ando R; Mizuno K; Tozawa K; Kohri K; Yasui T
BMC Urol; 2018 Mar; 18(1):19. PubMed ID: 29530009
[TBL] [Abstract][Full Text] [Related]
20. Three pathways for human kidney stone formation.
Coe FL; Evan AP; Worcester EM; Lingeman JE
Urol Res; 2010 Jun; 38(3):147-60. PubMed ID: 20411383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
